To commemorate Professor Davide Francesco D’Amico’s contributions to surgery, transplantation, academic leadership, and surgical education.
Approach:
Professional background: Trained in Padua under Professor Piergiuseppe Cevese, D’Amico became a leading figure in Italian hepatobiliary surgery and general surgery.
Professional milestones: He helped establish AICEB in 1982, contributed to founding Italian chapters of international hepatobiliary surgery organizations, and served as IHPBA president from 2006 to 2008.
Transplantation: He led Padua’s first liver transplant in 1990 and, with Koichi Tanaka, performed Italy’s first paediatric living-donor liver transplant in 1997.
Education and leadership: He led several surgical societies, directed surgical and transplant departments, authored textbooks, and developed a surgical school that encouraged trainees to gain experience abroad.
Key Findings:
D’Amico died in Padua on August 17, 2026, aged 90.
He helped shape Italian hepatobiliary surgery and transplantation through professional organizations, clinical milestones, and international collaboration.
After retiring in 2009, he was named Professor Emeritus of the University of Padua and continued advising his surgical school.
Interpretation:
The memorial presents D’Amico as a pioneering surgeon and influential academic whose legacy continued through his trainees and institutions.
Limitations:
This is a commemorative account and does not provide systematic data on clinical outcomes or the impact of his work.
Conclusion:
The article remembers D’Amico for his surgical achievements, leadership, mentorship, and lasting influence on Italian surgery.
According to Agilent Technologies, the expanded indication covers esophageal and gastric tumor types and applies to patients being considered for nivolumab or nivolumab and hyaluronidase-nvhy.
